SCHEMBL6906735

SCHEMBL6906735

CC(Sc1cnc(NC(=O)C2CCN(CCO)CC2)s1)c1ncc(C(C)(C)C)o1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 17/20 0.70
CCNE2 O96020 7/20 0.70
CCNE1 P24864 7/20 0.70
HDAC3 O15379 3/20 0.56
HDAC4 P56524 3/20 0.56
HDAC1 Q13547 3/20 0.56
HDAC7 Q8WUI4 3/20 0.56
HDAC2 Q92769 3/20 0.56
HDAC10 Q969S8 3/20 0.56
HDAC11 Q96DB2 3/20 0.56
HDAC8 Q9BY41 3/20 0.56
HDAC6 Q9UBN7 3/20 0.56
HDAC9 Q9UKV0 3/20 0.56
HDAC5 Q9UQL6 3/20 0.56
CDK9 P50750 12/20 0.51
CDK7 P50613 4/20 0.51
CCNT1 O60563 3/20 0.51
CCNH P51946 3/20 0.51
MNAT1 P51948 2/20 0.51
CCNA1 P78396 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6911670 0.88 CDK2 (0.56) CDK2CCNE2CCNE1HDAC3HDAC4
SCHEMBL4929170 0.82 CDK2 (1.00) CDK2CCNE2CCNE1HDAC3HDAC4
SCHEMBL6906730 0.81 CDK2 (0.84) CDK2CCNE2CCNE1HDAC3HDAC4
SCHEMBL6911527 0.80 CDK2 (0.68) CDK2CCNE2CCNE1CDK9CDK7
SCHEMBL26399636 0.75 CDK2 (0.85) CDK2CCNE2CCNE1HDAC3HDAC4
Hydrochloric Acid SCHEMBL26128863 0.74 CDK2 (0.84) CDK2CCNE2CCNE1HDAC3HDAC4
SCHEMBL14067130 0.73 HDAC3 (0.89) CDK2CCNE2CCNE1HDAC3HDAC4
SCHEMBL24758393 0.73 CDK2 (0.83) CDK2CCNE2CCNE1HDAC3HDAC4
SCHEMBL4996384 0.73 CDK2 (0.79) CDK2CCNE2CCNE1HDAC3HDAC4
SCHEMBL26129922 0.73 CDK2 (0.81) CDK2CCNE2CCNE1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1429764-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER Bristol-Myers Squibb Company (US) 2004-06-23 EP claimed
WO-2003020272-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2003-03-13 WO claimed